Nurse support is described as included throughout the treatment period
a RigiScan device as hereafter described, was attached 30 minutes pre- dose (T-30), where subjects were dosed at TO, with a first 30 minute visual sexual stimulation (VSS) session, utilizing subject-selected sexually graphic videos, occurring from 50 to 80 minutes post- dose (T50 to T80), and a second 30 minute VSS session occurring from 110 to 140 minutes post- dose (T110 to T140), with the RigiScan device continuing to monitor the subject until six (6) hours post-dose (a total of 6.5 hours)
N., Yalcin, O., Aydogdu, N., Turan, F
Prignano, F., Betts, C
Reduced Risk of Cardiovascular Events: Brightmeds Semaglutide lowers the risk of heart-related issues, such as heart attacks and strokes, in those with type 2 diabetes